Peripheral Blood Smears Distinguish Infective Fever after CAR-T Therapy
Open Access
- 24 November 2023
- journal article
- research article
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 28 (11) , 299
Abstract
Background: Chimeric antigen receptor (CAR) T-cell therapy carries the risk of inducing severe and life-threatening toxicities such as cytokine release syndrome (CRS), neurotoxicity, and infection. Although CRS and infections have similar symptoms, their treatment strategies differ, and early diagnosis is very important. For CRS and infections, the fastest detection time currently takes more than 24 h, so a quick and simple method to identify a fever after CAR T-cell infusion is urgently needed. Methods: We enrolled 27 patients with recurrent fever treated with different types of CAR T-cells, including cluster of differentiation (CD) 7, CD19, CD22, and CD19-CD22 bicistronic CAR T-cells, and evaluated the infection events occurring in these patients. We detailed the morphology of CAR T-cells in peripheral blood smears (PBS) and reported the infection events, CAR transgene copy number, and inflammatory indicators within the first month after treatment. Results: Similar morphological characteristics were observed in the PBS of different CAR T-cells, namely, enlarged cell bodies, deep outside and shallow inside basophilic blue cytoplasm, and natural killer (NK) cell-like purplish red granules. There were ten infections in nine of the twenty-seven patients (33%). The percentage of atypical lymphocytes in PBS was significantly associated with CAR transgene copy number and absolute lymphocyte count in all patients. The atypical lymphocyte percentage was significantly higher in the non-infection group. Conclusions: In conclusion, the unique morphology of CAR T-cells in PBS can be used to evaluate CAR T-cell kinetics and provide reliable evidence for the rapid early identification of fever after CAR T-cell infusion. Clinical Trial Registrations: ChiCTR-OPN-16008526; ChiCTR-OPN-16009847; ChiCTR2000038641; NCT05618041; NCT05388695.Keywords
Funding Information
- National Natural Science Foundation of China (82070217)
- National High Technology Research and Development Program of China (2021YFA1101502)
This publication has 36 references indexed in Scilit:
- Fulminant Streptococcus suis infection detected on peripheral blood smear: A case reportJournal of Infection and Chemotherapy, 2022
- Atypical Borrelia garinii infection in an immunocompromised patient mimicking high-grade lymphomaInternational Journal of Infectious Diseases, 2022
- Infection complications in febrile chimeric antigen receptor (CAR)‐T recipients during the peri‐CAR‐T cell treatment period examined using metagenomic next‐generation sequencing (mNGS)Cancer Communications, 2022
- CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell LymphomasTransplantation and Cellular Therapy, 2021
- Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?The Lancet Haematology, 2021
- Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphomaBlood Cancer Journal, 2020
- ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector CellsTransplantation and Cellular Therapy, 2019
- Image Processing Approach for Detection of Leukocytes in Peripheral Blood SmearsJournal of Medical Systems, 2019
- Development of a Robust Algorithm for Detection of Nuclei and Classification of White Blood Cells in Peripheral Blood Smear ImagesJournal of Medical Systems, 2018
- Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapyJournal of Immunological Methods, 2016